Leidos (NYSE:LDOS) will acquire the URAC-accredited commercial independent review organization for undisclosed terms. The deal is expected to close in Q3.
After the transaction closes, IMX will operate under QTC Management, a Leidos subsidiary.
QTC provides more than 3K independent medical exams and medical record reviews per day across the U.S. for key federal customers.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.